Press Release Lunit Highlights AI-Powered Pathology Insights Across Cancer Types at ESMO 2026 Five studies to be presented, with key research examining AI-based biomarker assessment… CISION PRNewswireOctober 20, 2026
Insilico Medicine and Servier Achieve First Milestone in AI-Driven R&D Collaboration, Triggering An undisclosed Milestone Payment Two programs under the multi-year R&D collaboration have initiated and completed target… CISION PRNewswireOctober 20, 2026
Metabolon Announces New Bioinformatics Application to Translate Metabolomic Biomarkers into Actionable Multiomic Hypotheses New bioinformatics application combines curated metabolite-protein knowledge, advanced network algorithms, interactive exploration,… CISION PRNewswireOctober 20, 2026
Press Release Antigravity Reveals New Follow Me Bundle, Available Online and at Best Buy LOS ANGELES, Oct. 20, 2026 /PRNewswire/ — Antigravity today announced the Follow Me… CISION PRNewswireOctober 20, 2026
Press Release Money20/20 USA Underway with NYSE as Exchange Partner: NYSE Content Update NYSE issues a pre-market daily advisory direct from the trading floor. NEW… CISION PRNewswireOctober 20, 2026
Press Release Tech Future Travel Starts Now: 2026 JETOUR Global Technology Experience Day Kicks Off WUHU, China, Oct. 20, 2026 /PRNewswire/ — The 2026 JETOUR Global Technology Experience… CISION PRNewswireOctober 20, 2026
Press Release G-NiiB GenieBiome Named an Inaugural Hong Kong New Industrialisation Elite Enterprise Recognition highlights Hong Kong’s strengthin university research translation and life and health… CISION PRNewswireOctober 20, 2026
Patronus Biotech Receives Ethical Approval to Begin First-in-Human Phase 1 Trial of Three Multi-Stage Vaccines Against Malaria in Australia Bellberry Limited Research Ethics Committee approves first-in-human study in Australia of Patronus… CISION PRNewswireOctober 20, 2026
